normal syngeneic and allogeneic lymphocyte populations. Leukemic AKR cells are capable of suppressing in vitro antibody responses of normal AKR lymphocytes as well as AKR cell-mediated responses to DBA mastocytomas (Panfili and Golub, to be published). We have chosen in vitro antibody production as a model system for investigating the suppressive mechanism of leukemic AKR cells. Our in vitro analysis of suppression by leukemic AKR cells suggests that the mechanism of immunosuppression in leukemic AKR mice is by direct cell contact, requires the tumor and normal cells to be syngeneic or semiallogeneic, and is overcome by an allogeneic effect.
Materials and Methods
Mice. AKR/J mice, 5-8 wk old, as well as retired breeders, were obtained from The Jackson Laboratories, Bar Harbor, Maine. CBA, C57BL/6, C57BL/10 (B10), B10.A, B10.BR, 129, C3H/Fe, AKR.M, C58, DBA/2, [C57BL/6 x DBA/2]F, (BDF,), [AKR x C57BL/10]F, (AKB10), and [AKR x DBA/2 F,] (AKD2F,) were bred in our animal facilities using stocks obtained from The Jackson Laboratories. AKR.H-2 b mice were the generous gift of Dr. Edward Boyse, Sloan-Kettering Institute, and the C57BL/6.AKR were the generous gift of Dr. Frank Lilly, Albert Einstein College of Medicine. Mice were housed five to a cage and maintained on high chlorine, low pH water.
AKR/J mice less than 4-mo old were used as a source of normal AKR cells, although older nonleukemic AKR mice gave normal responses. Overtly leukemic mice were characterized by their massively enlarged thymuses, spleens, lymph nodes, and livers.
In Vitro Cultures. In vitro immune responses were performed by the method of Mishell and
Dutton (27) . Lymphoid cells were cultured in 35-mm Falcon petri dishes (Falcon Plastics, Oxnard, Calif.) or, for cell contact experiments, in Karush type modified equilibrium dialysis chambers (Bellco Glass Inc., Vineland, N. J.) separated by 0.2 ~m Nuclepore filters (General Electric Co., Plesanton, Calif.) (28) .
Antigens and Assays.
Sheep red blood cells (SRBC) were obtained from Colorado Serum Co., Denver, Colo. and were used as immunogen at 107 cells per culture. Trinitrophenyl lipopolysaccharide (TNP-LPS) was prepared from trinitrobenzene sulfonic acid and lipopolysaccharide (LPS) by the method of Jacobs and Morrison (29) ; 0.1 ~g of TNP-LPS were added per culture. Plaque assays were performed by the Cunningham modification of the Jerne plaque assay (30) . Target cells consisted of SRBC or lightly-conjugated trinitrophenyl horse red blood cells (TNP-HRBC) prepared by the method of Rittenberg and Pratt (31) .
Irradiation of Cells.
Leukemic or normal cells were suspended to 107 cells/ml in Hank's balanced salt solution (Grand Island Biological Co., Berkeley, Calif.) plus 5% fetal calf serum (Grand Island Biological Co.) and X-irradiated at doses indicated in the text. The source was a GE Maxitron 300 machine (General Electric, Milwaukee, Wis.) operated at 250 kV and 15 mA with 0.25 cm Cu and 1-mm A1 filtration at a head height of 51 cm (34 cm for 8,000 R). A dose of 50 R/min (160 R/rain for 8,000 R) was delivered over a uniform area, as determined dosimetrically with a Victoreen dosimeter (Victoreen Instrument Div., VLN Corp., Cleveland, Ohio). Irradiated cells were washed in Hank's and counted before use.
Freezing Leukemic Cells. Spleens, livers, and lymph nodes from overtly leukemic mice were dispersed in Hank's balanced salt solution (Grand Island Biological Co.) plus 5% fetal calf serum (Grand Island Biological Co.). Cells were suspended to 2 × 107 per ml in Dulbecco's Modified Eagle's Medium (Grand Island Biological Co.) plus 5~ fetal calf serum and 8~ dimethyl sulfoxide (Baker-reagent grade), and sealed in vials in 1-ml aliquots. The vials were frozen in a -70°C freezer and then placed in liquid N~. Cells were thawed in a 37°C water bath and washed three times in buffer before use.
Results
Immune Unresponsiveness and Suppressive Effect of Leukemic AKR Cells. Spleen cells from overtly leukemic AKR mice do not respond to the thymus-dependent antigen SRBC and show a greatly reduced response to the thymus-independent antigen TNP-LPS in the in vitro Mishell-Dutton culture system (Table I) . When normal AKR spleen cells are mixed with equal numbers of leukemic spleen or thymus cells, their ability to respond to SRBC is nearly abolished, and their ability to respond to TNP-LPS is reduced (Table I) . Cells from the enlarged lymph nodes and livers of leukemic mice are also capable of suppressing the plaque-forming cells (PFC) responses of normal spleen cells (Table I) .
To establish the relationship between the degree of suppression and the proportion of leukemic cells added per culture, varying numbers of leukemic cells were added to a constant number (107) of normal cells (Fig. 1) . The degree of suppression observed varied with cells from different individual leukemic mice; 50% leukemic cells were usually required to reduce normal SRBC responses to less than 20% of control values, while 10% leukemic cells reduced responses to from 20 to 80% of control value. The variation in suppressive ability of cells from different mice may be a function of the proportion of leukemic cells present in the organ being used as a source of leukemic cells, and thus the degree of metastatis of the leukemia, or may reflect inherent differences in suppressive ability of different leukemic cells. Leukemic cells which have been stored frozen in liquid nitrogen maintain full suppressive ability, thus allowing repeated examination of cells from individual mice ( Table I ). The thymus-independent response of normal spleen cells to TNP-LPS was always more resistant to suppression by leukemic cells than the thymus-dependent response to SRBC (Fig. 1) ; however, this is probably because LPS is capable of overcoming immuno- suppression by leukemic cells (Roman and Golub, manuscript in preparation).
Leukemic cells obtained from mice bearing spontaneous leukemias did not replicate well in vitro, and thus the suppressive effect exerted by these cells could not be attributed to their simply having "overgrown" the cultures. As proof of this, leukemic cells which have been X-irradiated with 8,000 R still possess full suppressive ability (Fig. 1 D) .
Kinetics of Suppression.
To determine if development of the in vitro immune response was sensitive to inhibition by leukemic cells throughout the culture period, 107 leukemic cells were added to cultures containing 107 normal spleen cells plus SRBC at various days of culture. For consistency, frozen leukemic cells from the same mouse were used throughout the experiment. 107 normal spleen cells without added leukemic cells served as controls. Leukemic cells were added on days 0, 1, 2, 3, or 4, and cultures were assayed on day five, which was the day of peak control response. The results (Fig. 2) expressed as percent of control value show that leukemic cells were able to arrest further development of PFC even when added at the 4th day of culture.
Requirement for Cell Contact. To establish whether soluble factors play a role in leukemic cell suppression of normal PFC response, leukemic cells or mixtures of leukemic and normal cells were cultured for 4 days in MishellDutton culture conditions. Medium from these cultures was centrifuged and filtered through 0.45/~m filters or left unfiltered. 0.5 ml of the supernatant fluid was mixed with an equal volume of fresh medium and used to culture normal AKR spleen cells. The PFC responses of these cultures were not reduced, although the leukemic cells themselves, which had been in culture for 4 days, retained their immunosuppressive capabilities (Table II) .
To further establish the failure of leukemic cells to elaborate soluble suppressive factors, leukemic and normal cells were cultured opposite one another in Karush type chambers separated by 0.2 /~m Nuclepore filters as described by Calkins and Golub (28) . In such chambers medium is free to flow from one cell population to another, but cell contact is prohibited. The data in Table III show that normal cells grown transfilter from leukemic cells are able to generate normal anti-SRBC responses. This suggests that cell contact is needed for suppression.
Specificity of Suppression for Syngeneic Cells.
A requirement for cell contact between leukemic and normal cells could indicate that a specific recognition of cell surface moieties is necessary for suppression to occur. We therefore tested the ability of leukemic AKR cells to suppress a variety of allogeneic cells. (Table IV) . DBA/2 has the same M locus as AKR (M-l, 32) , and the 129 expresses the G~x Gross virus antigen, as does AKR (33) . Leukemic AKR cells are also unable to suppress allogeneic cells which differ from AKR in background, but have the same or part of the same H-2 haplotype as AKR (H-2k), such as C58, CBA, C3H, C57BL/6.AKR, A, B10.A, and B10.BR (Table V) . It is of interest that C58, which like AKR has a high incidence of leukemia, is not suppressed by leukemic Thus, it appears that neither background nor H-2 similarities alone are sufficient for a cell to be suppressed by leukemic AKR cells, and that any genetic difference which can result in an allogeneic reaction by normal cells toward foreign determinants on leukemic cells is sufficient to prevent suppression from occurring. We therefore investigated suppression in a semiallogeneic system in which the normal cells are unable to respond allogeneicaUy to leukemic cells. Under these conditions we found that the leukemic cells were able to suppress. This is shown in Table VII ; the Fls of AKR and two nonsuppressible strains (B10 and DBA/2) are suppressed by leukemic AKR cells.
Effect of Allogeneic Cells on Syngeneic Suppression. To determine whether an allogeneic reaction was sufficient to overcome suppression, small numbers of irradiated allogeneic cells were added to cultures of normal AKR spleen cells plus leukemic AKR cells. In this situation, the normal AKR cells are able to respond to determinants on the irradiated allogeneic cells. As shown in Table  VIII, (Table VIII) .
Discussion
The debate as to whether a state of immunological anergy is the cause or the effect of neoplasia has been a continuing one for many years (35, 36) . Our data suggest that in the case of AKR leukemias, at least, the neoplastic cells themselves can induce a state of anergy in normally functioning lymphocytes. This leukemia-mediated suppression of cells which might otherwise respond against the tumor cells could have great significance in terms of the pathogenesis of the leukemia in AKR mice. We have investigated the suppression of a thymus-dependent antibody response here, but we have established that cellmediated responses are suppressed by leukemic cells as well (Panfili and Golub, manuscript in preparation). The fact that such functionally diverse organs as thymus, spleen, lymph node, and liver contain immunosuppressive cells (Table  I) argues that the widely metastasized leukemic cells are themselves suppressing. However, it cannot yet be ruled out that transformed cells turn on suppressive function in normal cell populations, and that these cells have (or assume) a heterogeneous organ distribution. The nature of the suppressive cell or cells in leukemic AKR mice is currently under investigation.
The thymus-independent TNP-LPS response of normal AKR spleen cells is more resistant to suppression by leukemic cells than the thymus-dependent SRBC response (Table I and Fig. 1 ). This probably does not reflect inherent differences in sensitivity to suppression of either T or B cells, but more likely reflects the ability of LPS to overcome suppression (Roman and Golub, to be published). The cell type(s) which are sensitive to suppression by leukemic AKR cells is presently being investigated. However, the kinetic experiments (Fig. 2 ) would indicate that, at least in this situation, addition of leukemic cells after initiation of clonal expansion of B cells halts further B-cell proliferation. Addition of leukemic cells at later times during the culture period did not completely abolish PFC, suggesting that leukemic cells are not suppressing by killing spleen cells. The fact that leukemic AKR cells act as efficient immunosuppressants when added at any time during the 4-day culture period suggests a different mechanism of suppression than has been reported for other in vitro tumor suppressor systems in which tumor cells must be added within 24 h after initiation of culture in order to suppress (9, 15). Irradiated leukemic cells are fully suppressive (Table I) , which also suggests a different mechanism of suppression than is found with Friend virus-infected cells where X-ray and mitomycin C abolish suppressive ability (15) .
Leukemic AKR cells require contact with normal lymphocytes to suppress their immune responses (Tables II and III) . The fact that suppressive factors are not elaborated by leukemic cells explains why relatively large numbers of cells are required for efficient suppression. In those in vitro tumor suppression systems which are mediated by soluble factors, a significant degree of suppression may be achieved with relatively few tumor cells (9, 11, 15) .
This requirement for cell contact led us to explore the degree of surface antigenic homology required for suppression. Our data indicates that homology either within the H-2 region or in background genes alone is not sufficient to permit suppression by leukemic AKR cells, since a difference in either H-2 or background genes prevents suppression (Tables IV, V , and VI). The F,s of AKR and two nonsuppressible strains (B10 and DBA/2) were, however, suppressed (Table VII) . It is possible that two genetic loci are required for suppression, one within the H-2 region and one outside. On the other hand, it may be that cell surface homology is not required for suppression at all, but rather that any cell capable of making an allogeneic response to the leukemic cell determinants or to any other foreign cell surface antigens is able to escape suppression. The fact that normal AKR cells are not suppressed by leukemic AKR cells when irradiated allogeneic cells are present argues that this may be the case (Table VIII) . Bortin et al. reported a significant delay in onset of passaged AKR leukemia after injections of allogeneic cells, although these authors attributed this finding to a killing of leukemic cells by the allogeneic cells (37) .
If the immunosuppressive activity of the leukemic cell is important in the pathogenesis of the AKR thymic leukemia and the suppression can be overcome by allogeneic interaction, it may be possible to alter the course of the disease by treatment with allogeneic cells. Experiments along this line are now in progress. Note Added in Proof. The leukemic and normal AKR mice used in these experiments were female. We now have evidence that suppression across sex barriers is infrequent, probably due to recognition of male-female antigenic differences.
